VIA
NXTC icon

Vident Investment Advisory’s NextCure NXTC Stock Holding History

Vident Investment Advisory’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,303
Closed -$454K – 922
2020
Q3 		$454K Sell
4,303
-287
-6% -$35.3K 0.02% 687
2020
Q2 		$1.18M Buy
4,590
+2,228
+94% +$848K 0.06% 426
2020
Q1 		$1.05M Sell
2,362
-169
-7% -$90.3K 0.07% 379
2019
Q4 		$1.71M Buy
+2,531
New +$1.27M 0.11% 295

Other funds holding NXTC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Vident Investment Advisory's NXTC Position: Q4 2020 in Review

Vident Investment Advisory sold out of NextCure (NXTC) in Q4 2020, closing a stake of 4,303 shares — an estimated $454K sold.

Vident Investment Advisory first reported a position in NXTC in Q4 2019 and held it in 4 quarters. The position peaked at $1.71M in Q4 2019. 83 funds tracked by Wall St. Rank hold NXTC as of Q4 2020.

  • Vident Investment Advisory reported no remaining NextCure position as of Q4 2020 after selling out during the quarter.
  • Vident Investment Advisory sold 4,303 NextCure shares in Q4 2020, an estimated $454K.
  • Vident Investment Advisory first reported a position in NextCure in Q4 2019 and held it in 4 quarters.
  • Vident Investment Advisory's NextCure position peaked at $1.71M in Q4 2019.
  • 83 funds tracked by Wall St. Rank held NextCure as of Q4 2020.

Based on Vident Investment Advisory's 13F filing for Q4 2020, filed 8 Feb 2021.